VT Labs » Blog Archive » INTERMISSION & LUNCH BREAK

Photo Gallery | Video Gallery

Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.

Hello world
We congratulate all the participants for successful conduction of GIAN – JNU – Radiation Biology and its clinical application course 2022.
Congratulations!!! A Canadian patent entitled: “DMA, a bis-benzimidazole, confers radioprotection to the intestine via AKT/NFKB dual pathway activation” is accepted on 09/02/2022.
Hurray!!! Our lab got two more patent granted- A US and Canadian Patent, entitled: “Broad-spectrum antibacterial activity of novel Bis-benzimidazole targeting topoisomerase IA” accepted on Date 05/03/2022 and 25/04/2022 respectively.
We congratulate our student Urvashi to publish a perspective in Journal of Medicinal Chemistry,2022, 65, 9, 6454–6495, entitled as ‘Development of Azaindole based frameworks as Antiviral Agents and their future perspective’. https://pubmed.ncbi.nlm.nih.gov/35477274/